Earnings call transcript: PharmX posts 9% revenue growth in Q1 2026 as stock slips
Related news
-
Sera prognostics CMO Inglis sells $16,288 in shares
-
Trump says Taiwan agrees to buy 30% of LNG from Alaska pipeline project
-
Asia stocks edge higher as chipmakers rebound; China trade beats forecasts
-
Trump campaigns in Alaska, a conservative state feeling the pinch of high energy prices
-
Everpure chief accounting officer Mona Chu sells $773,956 in stock
-
Everpure director Andrew Brown sells $665,936 in company stock
-
IMF says Britain does not need to speed up fiscal consolidation
-
Fury Vs. Joshua Sold Out In 40 Minutes — And The Ringwalk Is Really Late